Jefferies Cuts Price Target on Regeneron (REGN) Following District Court Ruling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Regeneron (REGN) volatility flat into Amgen (AMGM) court victory
January 6, 2017 9:24 AM ESTRegeneron (NASDAQ: REGN) January weekly call option implied volatility is at 46, January is at 40, February is at 41; compared to its 52-week range of 28 to 56 as shares down trades in pre-market after Amgen (AMGN) court victory
... MoreBoosted by Apple, Wall Street parties like it's 19,999
January 6, 2017 7:22 AM ESTBy Noel Randewich
(Reuters) - The Dow came within one point of 20,000 for the first time on Friday and the Nasdaq and S&P 500 reached record highs, boosted by Apple, extending a two-month rally fueled by optimism about U.S. President-elect Donald Trump.
Apple (NASDAQ: AAPL) climbed 1.1 percent after Canada's Competition Bureau did not find sufficient evidence the iPhone maker had engaged in anti-competitive conduct, closing a two-year investigation into the company.
Wall Street has been on a tear since Trump won the U.S. election in November,... More
Regeneron (REGN) Falls 8% as Trading Resumes
January 6, 2017 7:12 AM ESTRegeneron (NASDAQ: REGN) is down 7.9% as trading resumes.
... MoreRegeneron (REGN) volatility flat into JPMorgan 35rh Annual Healthcare Conference
January 6, 2017 6:53 AM ESTRegeneron (NASDAQ: REGN) January weekly call option implied volatility is at 46, January is at 40, February is at 41; compared to its 52-week range of 28 to 56 into JPMorgan 35rh Annual Healthcare Conference in San Francisco.
... MoreRegeneron (REGN) set to resume trading at 07:10AM ET following negative ruling
January 6, 2017 6:41 AM ESTRegeneron (NASDAQ: REGN) is set to resume trading at 07:10AM ET following negative ruling.
... MoreRegeneron (REGN): Cutting Estimates On Praluent Injunction - Baird
January 6, 2017 6:27 AM ESTBaird analyst, Brian Skorney, reiterated his Neutral rating on shares of Regeneron Pharma (NASDAQ: REGN) and cut his price target to $369 from $379 after Amgen succeeded in getting a permanent injunction against sanofi/Regeneron for the marketing of the PCSK9 antibody,... More
After-Hours Stock Movers 01/05: (OGXI) (STML) (GPS) Higher; (RT) (GIII) (SUM) Lower (more...)
January 5, 2017 6:06 PM ESTToday's After-Hours Movers
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 59.4% HIGHER; and Achieve Life Science, Inc., a privately held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement under which OncoGenex will acquire Achieve in an all-stock transaction.
Stemline Therapeutics, Inc. (Nasdaq: STML) 22% HIGHER; announced today an agreement with the U.S. Food and Drug Administration (FDA) on the registration pathway for SL-401 in blastic plasmacytoid dendritic cell neoplasm (BPDCN). To support the filing of... More
Amgen (AMGN) Wins Ban on Sanofi's (SNY) Sales of Praluent Cholesterol Drug - Bloomberg
January 5, 2017 4:43 PM EST(Updated)
Amgen (NASDAQ: AMGN) won a court ruling that blocks Sanofi (NYSE: SNY) and Regeneron (NASDAQ: REGN) from selling Praluent in the U.S. because it infringes on Amgen's patents,... More
Regeneron (REGN) Halted, News Pending
January 5, 2017 4:41 PM ESTRegeneron (NASDAQ: REGN) Halted, News Pending
... More